Drawing for INCANTHERA

USPTO serial 87070001

INCANTHERA

Reviewed by CopyMark Law Group

Reg. 5724523Status 710
Filing date
Status date
Registration date
Apr 16, 2019
Examiner
FENNESSY, EDWARD JOHN
Law office
TMEG LAW OFFICE 101

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INCANTHERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey A Smith

JEFFREY A SMITH MILLEN, WHITE, ZELANO & BRANIGAN, P.C.2200 CLARENDON BOULEVARDSUITE 1400ARLINGTON, VA 22201

Goods and services

ClassDescriptionStatusFirst use
005Therapeutic pharmaceutical preparations for the treatment of cancer; therapeutic pharmaceutical preparations for the prevention of cancer; anti-cancer therapeutic pharmaceutical preparations; pharmaceutical preparations for cancer therapeutics; therapeutic pharmaceutical compounds for treating cancerSECTION 8 - CANCELLED—
042Scientific and technological services and research and design relating thereto, namely, medical research services, pharmaceutical drug development and pharmaceutical research and development; Scientific and technological services and research and design relating thereto, namely, medical and scientific research in the field of cancer treatment and diagnosis; scientific research, namely, scientific research; scientific and industrial research, namely, industrial research in the field of medical science and compiling data for research purposes in the field of medical science and medical consultancy; laboratory research services relating to pharmaceuticals; pharmaceutical product development; consultancy relating to research and development in the fields of pharmaceuticals and therapeutics; scientific and technological services and research and design relating thereto, namely, conducting clinical trials for others; industrial research, namely, compilation of data for research purposes in the field of medical science, research in the field of anti-cancer drug delivery systems; laboratory research services relating to pharmaceuticals; pharmaceutical product development; consultancy relating to research and development in the fields of pharmaceuticals and therapeuticsSECTION 8 - CANCELLED—
045Acquisition and licensing of intellectual property; licensing of technology, namely, computer software, hardware and medical devices, for medical research and cancer treatment purposes; licensing of technology, namely, computer software, hardware and medical devices, for research in the field of cancer treatment; licensing of technology, namely, computer software, hardware and medical devices, for use in the field of medical scienceSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2025C8..CANCELLED SEC. 8 (6-YR)—
Apr 16, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 16, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 21, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Feb 21, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Feb 12, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 9, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 9, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 9, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 9, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 9, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 19, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 13, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 11, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 11, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Apr 11, 2017CNSLSUSPENSION LETTER WRITTEN—
Mar 24, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 22, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 22, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 21, 2016DOCKASSIGNED TO EXAMINER—
Aug 23, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 16, 2016ALIEASSIGNED TO LIE—
Aug 8, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 22, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2016NWAPNEW APPLICATION ENTERED—
Jun 13, 2016FAXXFAX RECEIVED—

Frequently asked questions

Related guidance